We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Watson Settles Androderm False Marking Suit

Law360 (February 2, 2011, 4:25 PM EST) -- Watson Pharmaceuticals Inc. has agreed to stop using packaging for its Androderm testosterone deficiency treatment allegedly labeled with expired patents in order to settle a false marking suit accusing the company...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.